Canada Biotechnology & Medical Research

Eupraxia Pharmaceuticals Inc (EPRX)

Ticker: EPRX Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Eupraxia Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Montalbano, John Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
211.68
Quantity 13,740 -7.0%
Value US$28,922
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
106.98
Quantity 11,383 -46.8%
Value CA$2,564,514
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
264.25
Quantity 37,090 +46.7%
Value CA$2,323,864
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.44
Quantity 2,000 +5.4%
Value CA$18,880
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.40
Quantity 2,000 +5.7%
Value CA$18,800
2.9
Pimstone, Simon Neil Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.39
Quantity 2,500 +7.7%
Value CA$23,475
2.7
Geyer, Paul Director of Issuer Non-Executive Director
Transaction date
Sale
Price
10.80
Quantity 15,000 -30.8%
Value CA$162,000
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.65
Quantity 1,800 +5.1%
Value CA$19,169
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.72
Quantity 4,200 +59.7%
Value CA$45,003
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.90
Quantity 1,929 +5.2%
Value CA$21,026
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.83
Quantity 1,300 +3.7%
Value CA$14,084
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.89
Quantity 1,700 +0.5%
Value CA$18,519
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.91
Quantity 1,800 +0.5%
Value CA$19,638
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.88
Quantity 400 +0.1%
Value CA$4,352
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.17
Quantity 3,874 +11.7%
Value CA$39,386
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
10.90
Quantity 1,700 +0.1%
Value CA$18,533
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
7.00
Quantity 142,858 +9.6%
Value US$1,000,006
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.59
Quantity 125,622 +9.2%
Value CA$1,204,715
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
8.59
Quantity 7,037
Value CA$60,448
3.8
Freedman, Joseph Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
9.59
Quantity 4,483 +1.4%
Value CA$42,992
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-19 B Purchase
3.5
Montalbano, John

Director of Issuer

Non-Executive Director
13,740 -7.0%
211.68
US$28,922 		13,740 -7.0% 211.68 US$28,922
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
11,383 -46.8%
106.98
CA$2,564,514 		11,383 -46.8% 106.98 CA$2,564,514
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
37,090 +46.7%
264.25
CA$2,323,864 		37,090 +46.7% 264.25 CA$2,323,864
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
2,000 +5.4%
9.44
CA$18,880 		2,000 +5.4% 9.44 CA$18,880
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
2,000 +5.7%
9.40
CA$18,800 		2,000 +5.7% 9.40 CA$18,800
2026-03-27 2026-03-27 B Purchase
2.9
Pimstone, Simon Neil

Director of Issuer

Non-Executive Director
2,500 +7.7%
9.39
CA$23,475 		2,500 +7.7% 9.39 CA$23,475
2026-03-18 2026-03-18 S Sale
2.7
Geyer, Paul

Director of Issuer

Non-Executive Director
15,000 -30.8%
10.80
CA$162,000 		15,000 -30.8% 10.80 CA$162,000
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,800 +5.1%
10.65
CA$19,169 		1,800 +5.1% 10.65 CA$19,169
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
4,200 +59.7%
10.72
CA$45,003 		4,200 +59.7% 10.72 CA$45,003
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,929 +5.2%
10.90
CA$21,026 		1,929 +5.2% 10.90 CA$21,026
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,300 +3.7%
10.83
CA$14,084 		1,300 +3.7% 10.83 CA$14,084
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,700 +0.5%
10.89
CA$18,519 		1,700 +0.5% 10.89 CA$18,519
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,800 +0.5%
10.91
CA$19,638 		1,800 +0.5% 10.91 CA$19,638
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
400 +0.1%
10.88
CA$4,352 		400 +0.1% 10.88 CA$4,352
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
3,874 +11.7%
10.17
CA$39,386 		3,874 +11.7% 10.17 CA$39,386
2026-03-18 2026-03-18 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
1,700 +0.1%
10.90
CA$18,533 		1,700 +0.1% 10.90 CA$18,533
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
142,858 +9.6%
7.00
US$1,000,006 		142,858 +9.6% 7.00 US$1,000,006
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
125,622 +9.2%
9.59
CA$1,204,715 		125,622 +9.2% 9.59 CA$1,204,715
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
7,037
8.59
CA$60,448 		7,037 8.59 CA$60,448
2026-02-21 2026-02-20 B Purchase
3.8
Freedman, Joseph Stuart

Director of Issuer

Non-Executive Director
4,483 +1.4%
9.59
CA$42,992 		4,483 +1.4% 9.59 CA$42,992

See older Eupraxia Pharmaceuticals Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Eupraxia Pharmaceuticals Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Eupraxia Pharmaceuticals Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America